(Q71731853)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894580%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

In vitro activity and selection of disk content for disk diffusion susceptibility tests with trovafloxacin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894580%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

2

A L Barry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894580%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1

P C Fuchs

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894580%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

3

S D Brown

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894580%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author name string

D L Sewell

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894580%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 August 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894580%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Microbiology & Infectious Diseases

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894580%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894580%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894580%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

678-682

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894580%20AND%20SRC:MED&resulttype=core&format=json

In vitro activity of the new fluoroquinolone CP-99,219.

20 October 2019

cites work

1 reference

12 December 2020

In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone

1 reference

12 December 2020

Preliminary interpretive criteria for in vitro susceptibility testing of CP-99219 by dilution and disk diffusion methods.

1 reference

12 December 2020

In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria

1 reference

12 December 2020

Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.

1 reference

12 December 2020

Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01691159

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8894580%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference